Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies

Clinical trial NCT00504972 · COMPLETED

Trial details

NCT number: NCT00504972
Sponsor: Weill Medical College of Cornell University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma Chronic Lymphocytic Leukemia

Start date: 2007-06-01
Primary completion: 2011-04-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.